Now On Demand: Explore the Ethical Limits of Gene Therapy

As is typical with many medical advances, numerous questions exist about the boundaries of ethical use of gene and cell therapies. This Friday we’ll consider some of these questions about the relationship between science and society and discuss how to conduct responsible research during our free Professional Development Café, Scientific Horizons and Ethical Limits of Gene and Cell Therapy.

From 1-3 p.m. (CT) on Friday, Nov. 18, we’ll hear from ASGCT Members Ben Hurlbut, PhD, and Krishanu Saha, PhD, who will help us understand several foundational cases in biomedical research, like CRISPR, biobanking, and embryo culture. They’ll talk about how these cases have helped define ethical limits of the field and what it means to conduct research for the public good. Drs. Hurlbut and Saha will also explore the forms of deliberation, participation, exclusion, and oversight these cases exemplify.

As always, attendees are invited to bring questions to the session and contribute to what will be a collaborative discussion. If you haven't registered, you can do so on the event page. If you're already registered, access the event here at 1 p.m. this Friday. 

We hope to see you there and look forward to a lively discussion!

Watch On Demand

About the Speakers

Ben Hurlbut, PhD, is an associate professor in the School of Life Sciences at Arizona State University. His research focuses on the changing relationships between the science, politics, and law of biomedical research in the 20th and 21st centuries.

Krishanu Saha, PhD, is an associate professor at the Wisconsin Institute for Discovery at the University of Wisconsin-Madison. His interests are focused on using human stem cells together with emerging engineering methods in material science and synthetic biology to make smarter therapeutics, model human disease, and advance personalized medicine.

Related Articles